KR950008679A - 신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A,B,Y 및 아글리콘(Aglycone)의 제조방법 - Google Patents

신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A,B,Y 및 아글리콘(Aglycone)의 제조방법 Download PDF

Info

Publication number
KR950008679A
KR950008679A KR1019930017589A KR930017589A KR950008679A KR 950008679 A KR950008679 A KR 950008679A KR 1019930017589 A KR1019930017589 A KR 1019930017589A KR 930017589 A KR930017589 A KR 930017589A KR 950008679 A KR950008679 A KR 950008679A
Authority
KR
South Korea
Prior art keywords
aglycone
kctc
culture
dkrs
medium
Prior art date
Application number
KR1019930017589A
Other languages
English (en)
Other versions
KR970000591B1 (ko
Inventor
조원태
김완섭
김명국
박진규
김학열
이상기
돔라체바
파니치키나
사브로바
노비코바
발토체비치
Original Assignee
권기범
강재헌
동국제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 권기범, 강재헌, 동국제약 주식회사 filed Critical 권기범
Priority to KR1019930017589A priority Critical patent/KR970000591B1/ko
Priority to GB9400513A priority patent/GB2281563B/en
Priority to JP6002565A priority patent/JP2718002B2/ja
Priority to ITMI940035A priority patent/IT1273049B/it
Priority to ES09400079A priority patent/ES2078875B1/es
Priority to FR9400527A priority patent/FR2709497B1/fr
Priority to NL9400096A priority patent/NL9400096A/nl
Priority to DE4401546A priority patent/DE4401546C2/de
Priority to CA002113871A priority patent/CA2113871C/en
Priority to TW083100481A priority patent/TW258754B/zh
Priority to CH00304/94A priority patent/CH688151A5/fr
Priority to US08/192,165 priority patent/US5468637A/en
Priority to CN94105525A priority patent/CN1104682A/zh
Priority to CN 94105525 priority patent/CN1108694A/zh
Priority to US08/369,375 priority patent/US5484712A/en
Publication of KR950008679A publication Critical patent/KR950008679A/ko
Application granted granted Critical
Publication of KR970000591B1 publication Critical patent/KR970000591B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00—Preparation of compounds containing at least three condensed carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/56—Streptomyces lavendulae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

본 발명은 항암제인 아클라시노마이신들과 그의 아글리콘을 생산하는 스트렙토마이세스속 균주 및 이를 배양하여 아클라시노마이신들과 그의 아글리콘을 생산하는 방법을 제공한다. 본 발명의 균주 스트렙토마이세스 라벤도폴리아(Streptomyces lavendofoliae) DKRs(KCTC 8539P)는 아클라시노마이신 A와 B만을 생산하는 친주인 I2/3A와 달리 A, B, Y 및 아글리콘을 생산하며 그 수율도 높다.
한편 미생물 배양 후 배양액을 염산이나 초산 완충용액으로 처리하면 아클라시노마이신 A가 Y로 또는 Y가 A로 전환되는 것이 관찰되는데, 이는 미생물 자체의 트정 효소의 작용에 의해 일어나는 것으로 생각되며, 이런 작용을 이용하여 아클라시노마이신 A 또는 Y를 선택적으로 생산할 수 있다.

Description

신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A, B, Y 및 아글리콘(Aglycone)의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 아클라시노마이신 A, B, Y 및 아글리콘의 생산기능을 갖는 스트렙토마이세스 라벤도폴리아(Streptolmyces lavendofoliae) DKRs(KCTC 8539P).
  2. 제1항에 있어서, 배양후 배양액을 초산 완충액으로 pH 4.4로 보정하면 아클라시노마이신 A를 Y로 전환시키고, 배양액을 염산으로 pH 4.6으로 보정하면 아클라시노마신 Y를 A로 전환시키는 능력을 가짐을 특징으로 하는 스트렙토마이세스 라벤도폴리아(Streptomyces lavendofoliae) DKRS(KCTC 8539P).
  3. 스트렙토마이세스 라벤도폴리아(Streptomyces lavendofoliae) DKRS(KCTC 8539P)를 배지에 배양하여 아클라시노마이신 A, B, Y 및 아글리콘을 균체내 및 배양액에 축적한 후 균체 및 배양액으로부터 아클라시노마이신 A, B, Y 및 아글리콘을 회수하여 정제함을 특징으로 하는 발효법에 아클라시노마이신 A, B, Y 및 아글리콘의 제조방법.
  4. 제3항에 있어서, 배양은 28-30℃, pH6.8-7.5범위의 호기적 조건에서 4-5일간 실시함을 특징으로 하는 제조방법.
  5. 제3항에 있어서, 톨루엔과 이소프로파놀의 30 : 1-35 : 1부피비의 혼합 용매를 이용하여 아클라시노마이신 A, B, Y 및 아글리콘을 회수 및 정제함을 특징으로 하는 제조방법.
  6. 스트렙토마이세스 라벤도폴리아(Streptomyces lavendofoliae) DKRS(KCTC 8539P)를 배지에 배양하고, 배양액을 초산 완충용액으로 pH 4.4로 보정한 후 균체와 배양액으로부터 아클라시노마이신 Y를 분리함을 특징으로 하는 아클라시노마이신 Y의 제조방법.
  7. 스트렙토마이세스 라벤도폴리아(Streptomyces lavendofoliae) DKRS(KCTC 8539P)를 배지에배양하고, 배양액을 염산으로 pH 4.6으로 보정한 후 균체와 배양액으로부터 아클라시노마이신 A를 분리함을 특징으로 하는 아클라시노마이신 A의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930017589A 1993-09-03 1993-09-03 신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A, B, Y 및 아글리콘(Aglycone)의 제조방법 KR970000591B1 (ko)

Priority Applications (15)

Application Number Priority Date Filing Date Title
KR1019930017589A KR970000591B1 (ko) 1993-09-03 1993-09-03 신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A, B, Y 및 아글리콘(Aglycone)의 제조방법
GB9400513A GB2281563B (en) 1993-09-03 1994-01-12 A strain of streptomyces lavendofoliae dkrs & a method for producing aclacinomycins a,b,y & aglycone by using the same
JP6002565A JP2718002B2 (ja) 1993-09-03 1994-01-14 新菌株ストレプトマイセス・ラベンドフォリアｄｋｒｓならびにこれを用いたアクラシノマイシンａ，ｂ，ｙおよびアグリコンの製造方法
ITMI940035A IT1273049B (it) 1993-09-03 1994-01-14 Ceppo di streptomyces lavendofoliae dkrs e metodo per la sua utilizzazione nella produzione delle aclacinomicine a,b,y e dell'aglicone
ES09400079A ES2078875B1 (es) 1993-09-03 1994-01-17 Procedimiento para la produccion de aclacinomicinas a,b, y, y sus agluconas mediante el cultivo de la cepa streptomyces lavendofoliae dkrs.
FR9400527A FR2709497B1 (fr) 1993-09-03 1994-01-19 Souche de Streptomyces lavendofoliae DKRS et procédé de production des aclacinomycines A, B, Y et d'aglycone en utilisant ceux-ci.
NL9400096A NL9400096A (nl) 1993-09-03 1994-01-20 Nieuwe Streptomyces-stam en werkwijze voor het bereiden van antitumormiddelen daarmee.
DE4401546A DE4401546C2 (de) 1993-09-03 1994-01-20 Streptomyces lavendofoliae DRKS Stamm, Verfahren zur Gewinnung der Aclacinomycine A, B, Y und von Aglycon durch Anwendung dieses Verfahrens
CA002113871A CA2113871C (en) 1993-09-03 1994-01-20 A strain of streptomyces lavendofoliae dkrs and a method for producing aclacinomycins a,b,y and aglycones using the same
TW083100481A TW258754B (ko) 1993-09-03 1994-01-20
CH00304/94A CH688151A5 (fr) 1993-09-03 1994-02-02 Souche de streptomyces lavendofoliae DKRS et procédé de production des aclacinomycines A, B, Y et d'aglycone en utilisant ceux-ci.
US08/192,165 US5468637A (en) 1993-09-03 1994-02-04 S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones
CN94105525A CN1104682A (zh) 1993-09-03 1994-05-17 一种淡紫灰叶链霉菌dkrs菌株及用它制备阿克拉希霉素a，b，y和糖苷配基的方法
CN 94105525 CN1108694A (zh) 1993-09-03 1994-05-17 一种淡紫灰叶链霉菌dkrs菌株及用它制备阿克拉希霉素a，b，y和糖苷配基的方法
US08/369,375 US5484712A (en) 1993-09-03 1995-01-06 Method for producing aclacinomycins A, B, Y using Strepomyces lavendofoliae DKRS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930017589A KR970000591B1 (ko) 1993-09-03 1993-09-03 신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A, B, Y 및 아글리콘(Aglycone)의 제조방법

Publications (2)

Publication Number Publication Date
KR950008679A true KR950008679A (ko) 1995-04-19
KR970000591B1 KR970000591B1 (ko) 1997-01-14

Family

ID=19362801

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930017589A KR970000591B1 (ko) 1993-09-03 1993-09-03 신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A, B, Y 및 아글리콘(Aglycone)의 제조방법

Country Status (13)

Country Link
US (2) US5468637A (ko)
JP (1) JP2718002B2 (ko)
KR (1) KR970000591B1 (ko)
CN (2) CN1108694A (ko)
CA (1) CA2113871C (ko)
CH (1) CH688151A5 (ko)
DE (1) DE4401546C2 (ko)
ES (1) ES2078875B1 (ko)
FR (1) FR2709497B1 (ko)
GB (1) GB2281563B (ko)
IT (1) IT1273049B (ko)
NL (1) NL9400096A (ko)
TW (1) TW258754B (ko)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071411A (en) * 1974-07-27 1978-01-31 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Antitumor antibiotics aclacinomycins A and B [RD-9187A]
JPS5134915B2 (ko) * 1974-07-27 1976-09-29
US4204038A (en) * 1976-04-07 1980-05-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Process for preparing antibiotics MA 144-M1 and MA 144-M2
US4209588A (en) * 1976-10-05 1980-06-24 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Process for producing new antitumor anthracycline antibiotics
NL176004C (nl) * 1976-10-05 1985-02-01 Microbial Chem Res Found Werkwijze ter bereiding van geneesmiddelen met antitumorwerking op basis van anthracycline glycosiden en werkwijze ter bereiding van daartoe dienende anthracycline glycosiden.
JPS5648893A (en) * 1979-09-07 1981-05-02 Sanraku Inc Preparation of anthracycline glycoside
EP0050724B1 (en) * 1980-10-27 1985-01-09 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Process for anthracycline glycosides
DE3164574D1 (en) * 1980-10-27 1984-08-09 Hoffmann La Roche Process for aclacinomycins and microorganism used therein
US4405713A (en) * 1981-12-28 1983-09-20 Hoffmann-La Roche Inc. Process for the preparation of optically active anthracycline glycosides A and B
US4471052A (en) * 1982-01-18 1984-09-11 Adria Laboratories, Inc. Biosynthesis of simplified anthracyclines
SU1069433A1 (ru) * 1982-06-29 1984-11-23 Всесоюзный научно-исследовательский институт антибиотиков Штамм @ @ 12/3а-продуцент аклациномицинов @ и @

Also Published As

Publication number Publication date
CN1104682A (zh) 1995-07-05
IT1273049B (it) 1997-07-01
ES2078875B1 (es) 1996-08-16
ITMI940035A1 (it) 1995-07-14
US5484712A (en) 1996-01-16
KR970000591B1 (ko) 1997-01-14
JP2718002B2 (ja) 1998-02-25
ITMI940035A0 (it) 1994-01-14
JPH0775575A (ja) 1995-03-20
TW258754B (ko) 1995-10-01
DE4401546A1 (de) 1995-03-30
FR2709497B1 (fr) 1996-11-15
GB2281563A (en) 1995-03-08
CN1108694A (zh) 1995-07-05
US5468637A (en) 1995-11-21
DE4401546C2 (de) 1997-09-25
GB9400513D0 (en) 1994-03-09
ES2078875A1 (es) 1995-12-16
CA2113871A1 (en) 1995-03-04
FR2709497A1 (fr) 1995-03-10
CH688151A5 (fr) 1997-05-30
CA2113871C (en) 2000-01-18
NL9400096A (nl) 1995-04-03
GB2281563B (en) 1998-01-28

Similar Documents

Publication Publication Date Title
KR950701976A (ko) F0-1289 물질 및 그의 생산방법
KR960700346A (ko) 면역억제제의 제조방법 및 이에 사용되는 신규 미생물(a process for producing immunosuppressives and a novel microbial species to be employed therein)
CA2252725C (en) A process for the biotransformation of colchicinoid compounds into the corresponding 3-glycosyl derivatives
KR930013124A (ko) 미생물에 의한 트랜스-4-히드록시-l-프롤린의 제조방법
KR970001000B1 (ko) 아미노디옥시만니톨의 제법
KR950008679A (ko) 신균주 스트렙토마이세스 라벤도폴리아 DKRS 및 이를 이용한 아클라시노마이신 A,B,Y 및 아글리콘(Aglycone)의 제조방법
KR100339715B1 (ko) 고농도 당성분을 포함하는 식품가공 부산물을 이용한고분자 중합체 풀루란의 제조방법
KR940005792A (ko) 다당류(polysaccharides)의 효소 정화
RU2218409C2 (ru) Способ биотрансформации колхиконового соединения в соответствующее 3-0-гликозильное производное
KR100414952B1 (ko) 식품가공 부산물인 간장박을 이용한 고분자 중합체풀루란의 제조방법
KR970062047A (ko) 오우레오바시디움속 미생물 gm21을 이용한 고순도 플루란의 제조방법
GB1451020A (en) Process for producing bacterial cells
AU634148B2 (en) Use of cellulase preparations in the cultivation and use of cellulose-producing microorganisms
US5869319A (en) Bile acid-converting microorganism Bacillus sp. and a method of use
KR940002357A (ko) 미생물을 이용한 사이클로덱스트린 글루카노트랜스퍼라제(Cyclodextrin Glucanotransferase)의 제조방법
KR900001714A (ko) 4'-데옥시-4'-요오독소루비신의 미생물에 의한 입체 선택적 환원으로 수득된 항종양제
KR940019866A (ko) 미생물 직접 발효에 의한 사이클로덱스트린(Cyclodextrin)의 제조방법
KR960014621B1 (ko) 신 균주 스트렙토마이세스 라벤도폴리아 dk-506 및 이를 이용한 아클라시노마이신 a의 제조와 분리정제 방법
KR910018554A (ko) 발효법에 의한 d-이소구연산 (d-isocitric acid)의 제조방법
KR950014298A (ko) 엘-메티오닌 유사체에 내성을 갖는 스트렙토미세스속 미생물 및 이를 이용한 아드리아마이신의 제조방법
JPH11127888A (ja) キシログルカンオリゴ９糖の大量製造方法
JPH05276970A (ja) 微生物によるキシロシルフラクトシド高含有糖液の 製造方法
KR950000886A (ko) 에리스리톨의 제조방법
KR950014313A (ko) 발효에 의한 아드리아마이신의 제조방법
KR970059268A (ko) 사이클로스포린에이의 제조방법 및 변이미생물

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010103

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee